Literature DB >> 103110

Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.

J Gerlach, H Simmelsgaard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 103110     DOI: 10.1007/bf00427742

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  31 in total

1.  Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia.

Authors:  J Gerlach; N Reisby; A Randrup
Journal:  Psychopharmacologia       Date:  1974-01-09

Review 2.  Persistent dyskinesia.

Authors:  G E Crane
Journal:  Br J Psychiatry       Date:  1973-04       Impact factor: 9.319

3.  Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.

Authors:  H Kazamatsuri; C Chien; J O Cole
Journal:  Arch Gen Psychiatry       Date:  1972-07

4.  Combined nitoman-pimozide treatment of Huntington's chorea and other hyperkinetic syndromes.

Authors:  R Fog; H Pakkenberg
Journal:  Acta Neurol Scand       Date:  1970       Impact factor: 3.209

Review 5.  Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.

Authors:  G E Crane
Journal:  Am J Psychiatry       Date:  1968-02       Impact factor: 18.112

6.  Tardive dyskinesia: its relation to neuroleptic and antiparkinson drugs.

Authors:  I Turek; A A Kurland; T E Hanlon; M Bohm
Journal:  Br J Psychiatry       Date:  1972-12       Impact factor: 9.319

7.  [Extrapyramidal symptoms following Clozapine therapy. Case report].

Authors:  S Doepp; C Buddeberg
Journal:  Nervenarzt       Date:  1975-10       Impact factor: 1.214

8.  Tardive dyskinesia treated with pimozide.

Authors:  L E Claveria; P F Teychenne; D B Calne; L Haskayne; A Petrie; C A Pallis; I C Lodge-Patch
Journal:  J Neurol Sci       Date:  1975-04       Impact factor: 3.181

9.  Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.

Authors:  A C Sayers; H R Bürki; W Ruch; H Asper
Journal:  Psychopharmacologia       Date:  1975

10.  Effect of cholinergic and anticholinergic agents on tardive dyskinesia.

Authors:  H L Klawans; R Rubovits
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-08       Impact factor: 10.154

View more
  23 in total

1.  Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia--a retrospective study of 387 patients.

Authors:  D Naber; M Leppig; R Grohmann; H Hippius
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Tolerability of long term clozapine treatment.

Authors:  M Schmauss; R Wolff; A Erfurth; E Rüther
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Multiple neurochemical action of clozapine: a quantitative autoradiographic study of DA2, opiate and benzodiazepine receptors in the rat brain after long-term treatment.

Authors:  L Giardino; L Calzà; P V Piazza; G Amato
Journal:  J Neural Transm Gen Sect       Date:  1991

4.  Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study.

Authors:  J A Stamford; Z L Kruk; J Millar
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

5.  Treatment schedule as a determinant of the development of tolerance to haloperidol.

Authors:  R J Carey; J DeVeaugh-Geiss
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat.

Authors:  H Lai; M A Carino; A Horita
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Oxiperomide in tardive dyskinesia.

Authors:  D E Casey; J Gerlach
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-03       Impact factor: 10.154

8.  Neuroleptic-induced acute dyskinesias in rhesus monkeys.

Authors:  R D Porsolt; M Jalfre
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.

Authors:  R Rivest; C A Marsden
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

10.  Fluperlapine in tardive dyskinesia and parkinsonism.

Authors:  S Korsgaard; U Noring; J Gerlach
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.